Modulight Biotherapeutics is developing a transformative optogenetic platform that precisely targets pathological neural activity when and where it occurs to restore balance in the nervous system.
Investors 1
Mentions in press and media 3
| Date | Title | Description |
| 12.11.2025 | Modulight Biotherapeutics Inks $12M Seed Funding |
BOSTON, MA, Modulight Biotherapeutics, developer of novel optogenetic platform for the treatment of neurological disorders, announced the closing of its Seed funding round raising $12.2 million.
>> Click here for more funding data on... |
| 12.11.2025 | Modulight Biotherapeutics Raises $12M in Seed Funding | Modulight Biotherapeutics, a Boston, MA-based developer of novel optogenetic platform for the treatment of neurological disorders, raised $12.2M in Seed funding.
The round was led by Jibe Ventures and LocalGlobe, with participation from Nex... |
| - | Modulight Bio | “HOME | Modulight.bio” |
Reviews 0
